Hot Topics in Pharmacology

Coronavirus Information

We collate information related to SARS-CoV-2 and COVID-19 on a dedicated coronavirus information page. This contains details of ligands and targets relevant to COVID-19 and links to useful resources and publications.

Recent publications of interest recommended by NC-IUPHAR

2026: Oct | Sept | Aug | Jul | Jun | May | Apr | Mar | Feb | Jan
2025: Dec | Nov

    October 2026


  • Distinct functional open states of the polymodal nociceptor TRPV1.
    Lee BH, Li S, Vu S, Yao Z, Tian Y, Yarov-Yarovoy V, Zheng J. Distinct functional open states of the polymodal nociceptor TRPV1. (2026)  Proc Natl Acad Sci U S A, 123 (42): e2614335123. [PMID:42879484]

  • A GPRC5B-Fyn signaling axis regulates VRAC activity by targeting LRRC8A.
    Kostritskaia Y, Gaitán-Peñas H, Bertelli S, Alonso-Gardón M, Klüssendorf M, Castellanos A, Pont-Espinós G, Pla-Casillanis A, González-Subías M, Errasti-Murugarren E et al.. A GPRC5B-Fyn signaling axis regulates VRAC activity by targeting LRRC8A. (2026)  Proc Natl Acad Sci U S A, 123 (42): e2606899123. [PMID:42879478]

  • Characterization of Lysosomal Hydrolases and Transporters and Their Age-Dependent Variability: Relevance to Drug Metabolism and Transport of Small Molecule and Biologic Drugs.
    Gadara D, Singh DK, Subash S, Yue G, Ahire D, Bohl C, Czerwinski M, Helmstetter S, Heyward S, Jones RS et al.. Characterization of Lysosomal Hydrolases and Transporters and Their Age-Dependent Variability: Relevance to Drug Metabolism and Transport of Small Molecule and Biologic Drugs. (2026)  Clin Pharmacol Ther, 120 (5): 1338-1347. [PMID:42198901]

  • MPDD: A Curated Database Bridging Membrane Protein-Drug-Disease Landscapes.
    Lu Z, Ma J, Yang J, Wang F, Zhu X, Yang G. MPDD: A Curated Database Bridging Membrane Protein-Drug-Disease Landscapes. (2026)  ACS Omega, 11 (41): 63734-63743. [PMID:42923984]

  • An integrative transcriptomic atlas of ALS and aging skeletal muscle defines shared and distinct molecular programs of degeneration.
    Grima-Terrén M, Rommelfanger M, Campanario S, Calls-Cobos A, Cisneros A, Ramírez-Pardo I, Chou G, Zheng Y, Hah N, Serrano AL et al.. An integrative transcriptomic atlas of ALS and aging skeletal muscle defines shared and distinct molecular programs of degeneration. (2026)  Proc Natl Acad Sci U S A, 123 (42): e2613546123. [PMID:42879493]

  • A gut microbial odd-chain fatty acid alleviates atherosclerosis in mice.
    Yin C, Chen Y, Lin G, Cai M, Pang C, Xiao X, Han K, Mei C, Qin M, Fan P et al.. A gut microbial odd-chain fatty acid alleviates atherosclerosis in mice. (2026)  Nature, [Epub ahead of print]. [PMID:42844473]

  • 5-oxoETE links redox control of epithelial damage detection and resilience.
    Ma Y, Lengyel M, Hui KL, Ambaw YA, Gelashvili Z, Kim L, Ly R, Peng S, Quraishi M, Walther TC et al.. 5-oxoETE links redox control of epithelial damage detection and resilience. (2026)  Nature, [Epub ahead of print]. [PMID:42844471]

  • Global and regional reference curves for pain across the lifespan in 6.1 million individuals in 118 countries.
    Fillingim M, Tanguay-Sabourin C, Neuert L, Zare A, Norman J, Guglietti GV, Hobeika L, Ayorinde A, Salimzadeh A, Jamshidi AR et al.. Global and regional reference curves for pain across the lifespan in 6.1 million individuals in 118 countries. (2026)  Nat Med, [Epub ahead of print]. [PMID:42834228]

  • Proteome-guided drug discovery maps and mitigates therapeutic degrader toxicity.
    Basu S, Yu JSL, Bosak J, Bagal SK, Crafter C, Fallan C, Lemke O, Freiwald A, White MEH, Vernardis SI et al.. Proteome-guided drug discovery maps and mitigates therapeutic degrader toxicity. (2026)  Nat Chem Biol, [Epub ahead of print]. [PMID:42855516]

  • GPCR antagonism via rewiring of receptor trafficking and degradation.
    Rhee K, Shue L, Adachi A, Sun P, Osei-Owusu J, Zhou D, Cheng A, Xu YR, Li Q, Baluapuri A et al.. GPCR antagonism via rewiring of receptor trafficking and degradation. (2026)  Nature, [Epub ahead of print]. [PMID:42816619]

  • TRI-611, a selective, brain-penetrant molecular glue degrader of ALK.
    Conery AR, La DS, Alekseyenko AA, Marcoux D, Bart AG, Harlow ML, Arsenault PR, Cantone NR, Casaubon RL, Constan A et al.. TRI-611, a selective, brain-penetrant molecular glue degrader of ALK. (2026)  Nature, 658 (8134): 241-249. [PMID:42717093]

  • Discovery of an antagonist nanobody targeting the oxytocin receptor with tocolytic effect in mice.
    Nie J, Gao K, Zhang X, Meng H, Li Q, Zhang X, Wu Y, Zeng H, Liu W, Liu L et al.. Discovery of an antagonist nanobody targeting the oxytocin receptor with tocolytic effect in mice. (2026)  Nat Commun, 17 (1). [PMID:42864336]

  • TM184C is a GPCR-like regulator of intercellular exchange and autophagy.
    Lee KD, Taylor S, Arcuri J, Chandthakuri S, Pujols J, Colon B, Wang Q, Wu C, Meng Z, Thompson-Ceccato SJ et al.. TM184C is a GPCR-like regulator of intercellular exchange and autophagy. (2026)  Nature, 657 (8132): 833-843. [PMID:42717083]

  • PLA2G2D in tumour-draining lymph nodes regulates anti-tumour immunity.
    van Krimpen A, Huang J, Eterman M, Gerretsen V, Umetani M, Janssen JC, van Nimwegen M, Rozendaal N, van den Bosch TPP, Jiang X et al.. PLA2G2D in tumour-draining lymph nodes regulates anti-tumour immunity. (2026)  Nature, 658 (8135): 485-495. [PMID:42717091]

  • Structure-Guided Identification of GPR84 Ligand Candidates With Potential Immunomodulatory Activities.
    Pham HT, Morales-Alvarez A, Gilbertson T, Nguyen H. Structure-Guided Identification of GPR84 Ligand Candidates With Potential Immunomodulatory Activities. (2026)  ChemMedChem, 21 (17): e70488. [PMID:42705849]

  • Microglia stabilize sleep homeostasis via adenosine A3 receptor signaling.
    Zhao Z, Gu X, Yu J, Chen X, Zhang L, Zhao T, Ye W, Cheng H. Microglia stabilize sleep homeostasis via adenosine A3 receptor signaling. (2026)  Sci Adv, 12 (37): eaef3957. [PMID:42726883]

  • The cellular landscape of druggable RNA-binding proteins.
    Di Timoteo G, George BM, Abdel-Wahab O, Flynn RA, Tzelepis K. The cellular landscape of druggable RNA-binding proteins. (2026)  Nat Rev Drug Discov, [Epub ahead of print]. [PMID:42811101]

  • Soft drugs: design principles and topical applications.
    Pirali T, Accetta A, Rautio J, Carzaniga L. Soft drugs: design principles and topical applications. (2026)  Nat Rev Drug Discov, [Epub ahead of print]. [PMID:42816649]

  • Mitochondrial carrier SLC25A34 links clock, diet, and temperature control of adipocyte lipid cycling
    Karavaeva I, Basse AL, Trammell SAJ, Hussain MF, Markussen LK, Havelund JF, Isidor MS, Chatoff A, Andress Huacachino A, Richter HJ et al.. Mitochondrial carrier SLC25A34 links clock, diet, and temperature control of adipocyte lipid cycling. (2026)  Science, 394 (6819): eadz4797. [PMID:42821689]
    van der Laan M. A mitochondrial carrier turns on the heat. (2026)  Science, 394 (6819): 29-30. [PMID:42821704]

  • Lipid Activation of a Thalamic GPCR Extends Working Memory Time-scales.
    Brandt JN, Bonito-Oliva A, Paknejad N, Chen C, Fak J, Luskin A, Rankin G, Kirylo M, Sibener LJ, Arnsten AFT et al.. Lipid Activation of a Thalamic GPCR Extends Working Memory Time-scales. (2026)  bioRxiv,. [PMID:42818673]

  • Quantification of lipid sorting during clathrin-mediated endocytosis.
    Lennartz HM, da Costa Nunes S, Böhlig K, Chhatre A, Šachl R, Kuhn SM, Moneta L, Barahtjan P, Yee Yau W, Iglesias-Artola JM et al.. Quantification of lipid sorting during clathrin-mediated endocytosis. (2026)  Nat Cell Biol, 28 (10): 2027-2035. [PMID:42811108]

  • Lysophospholipase PNPLA7 is a critical checkpoint of phosphatidylcholine catabolism and turnover for skeletal muscle homeostasis.
    Matsumoto S, Seo H, Taketomi Y, Higashi T, Nagasaki Y, Sato H, Kawaguchi M, Nishito Y, Park J, Mizuguchi K et al.. Lysophospholipase PNPLA7 is a critical checkpoint of phosphatidylcholine catabolism and turnover for skeletal muscle homeostasis. (2026)  Cell Rep,: 118003 [Epub ahead of print]. [PMID:42815479]

  • Mammals produce cyclo-octasulfur to suppress lipid peroxidation and ferroptosis
    Barayeu U, Ogata S, Takata T, Jung M, Matsunaga T, Morita M, Ida T, Lange M, Unno Y, Boushehri S et al.. Mammals produce cyclo-octasulfur to suppress lipid peroxidation and ferroptosis. (2026)  Science, 393 (6818): eaec5473. [PMID:42784683]
    Possemato R. King sulfur. (2026)  Science, 393 (6818): 1300-1301. [PMID:42784699]

  • TRPM2 is a direct pain transducer.
    Varghese L, Alizada M, Yang J, Feng Y, Yuan X, Malhotra M, Zhang X. TRPM2 is a direct pain transducer. (2026)  Proc Natl Acad Sci U S A, 123 (38): e2532289123. [PMID:42748138]

  • G protein diffusion states reveal receptor binding dynamics at single-molecule scale.
    Mathiasen S, Meszaros J, Webb C, Geggier P, Asher WB, Lambert NA, Javitch JA. G protein diffusion states reveal receptor binding dynamics at single-molecule scale. (2026)  Cell Chem Biol, [Epub ahead of print]. [PMID:42767220]

  • Deconstruction of lysergic acid diethylamide.
    Basargin AG, Domokos A, Hennessey JJ, Aarrestad IK, Sambyal R, Khatib YA, Krüger J, Dunlap LE, Carter SJ, Rebek IA et al.. Deconstruction of lysergic acid diethylamide. (2026)  Proc Natl Acad Sci U S A, 123 (38): e2603412123. [PMID:42709856]

  • Targeting an atypical G protein-coupled receptor signaling pathway for cardiac fibrosis therapy.
    Zhang H, Shivnaraine RV, Ren L, Thai PN, Janicot R, Zhu W, Huang R, Siepe DH, Tu C, Liu W et al.. Targeting an atypical G protein-coupled receptor signaling pathway for cardiac fibrosis therapy. (2026)  Science, 393 (6818): eaej5896. [PMID:42784676]

  • The lipidomic architecture of the mouse brain
    Fusar Bassini L, Schede HH, Capolupo L, Haj Abdullah Alieh L, Kaysudu I, Venturi F, Hochgerner H, Valente A, Droin C, Trejo Banos D et al.. The lipidomic architecture of the mouse brain. (2026)  Nature, 658 (8134): 205-217. [PMID:42778605]
    Macosko E. Brain lipids are organized into zones - and reorganized during pregnancy. (2026)  Nature, 658 (8134): 43-44. [PMID:42778731]

  • September 2026


  • The evolving landscape of drug targets.
    Halip L, Avram S, Overington JP, Al-Lazikani B, Curpan R, Sirimulla S, Pushechnikov A, Beccari AR, Savchuck N, Oprea TI. The evolving landscape of drug targets. (2026)  Nat Rev Drug Discov, [Epub ahead of print]. [PMID:42768085]

  • Lipid-mediated activation of BLT2 promotes membrane repair to prevent cell death.
    Chi Y, Saeki K, Yasukawa K, Kakuta S, Koga T, Yokomizo T. Lipid-mediated activation of BLT2 promotes membrane repair to prevent cell death. (2026)  J Cell Biol, 225 (10). [PMID:42690235]

  • Solute carrier membrane transporters: emerging targets in CNS disorders.
    Law YK, Glück S, Girardi E, Bensimon A, Angermayr SA, Superti-Furga G. Solute carrier membrane transporters: emerging targets in CNS disorders. (2026)  Nat Rev Drug Discov, [Epub ahead of print]. [PMID:42680881]

  • Development of diversified HTS cell-based assays for solute carrier drug discovery.
    Sassone F, Koch J, Batoulis H, Tremolada S, Ricci F, Maresca G, Ehrmann A, Scarabottolo L. Development of diversified HTS cell-based assays for solute carrier drug discovery. (2026)  SLAS Discov, 43: 100333. [PMID:42648491]

  • Interleukin-33 and its receptor: multifaceted roles and emerging therapeutic potential.
    Serve S, Löhning M. Interleukin-33 and its receptor: multifaceted roles and emerging therapeutic potential. (2026)  Nat Rev Immunol, [Epub ahead of print]. [PMID:42686822]

  • Whole-exome sequencing in individuals with obsessive-compulsive disorder and chronic tic disorders identifies 36 large-effect risk genes.
    Wang B, Tran MN, Wang S, Liu Y, Olfson E, Wang G, Sun N, Dea J, Olwal CO, Bertolace L et al.. Whole-exome sequencing in individuals with obsessive-compulsive disorder and chronic tic disorders identifies 36 large-effect risk genes. (2026)  Nat Neurosci, [Epub ahead of print]. [PMID:42680906]

  • A divergent betacoronavirus with a functional furin cleavage site in South American bats.
    Takada K, Yamahoki N, Mifsud JCO et al.. A divergent betacoronavirus with a functional furin cleavage site in South American bats. (2026)  Nat Commun, [Epub ahead of print]. DOI: 10.1038/s41467-026-77599-6

  • Cross-species single-cell atlas of the striatum defines cell-type and subregion disease vulnerabilities.
    Linville RM, James BT, Galani K, Ho LL, Shin JH, Oliver E, Fass SB, Cameron JC, Fitzwalter BE, Bock R et al.. Cross-species single-cell atlas of the striatum defines cell-type and subregion disease vulnerabilities. (2026)  Cell, [Epub ahead of print]. [PMID:42679819]

  • A single-point mutation in TRPA1 drives heat resilience in oviparous embryos.
    Feng TY, Dong W, Zheng D, Han L, Chen J, Wu X, Lu X, Yang S, Du WG. A single-point mutation in TRPA1 drives heat resilience in oviparous embryos. (2026)  Sci Adv, 12 (36): eaee3948. [PMID:42685214]

  • Proteomic profiling of drug and nutrient transporter expression by small intestinal region in neonates, pediatrics, and adults.
    Sun VL, Wang K, Kelly EJ, Arnold SLM. Proteomic profiling of drug and nutrient transporter expression by small intestinal region in neonates, pediatrics, and adults. (2026)  bioRxiv, [Preprint]. [PMID:42367886]

  • Universal pipeline for high-resolution GPCR structure determination.
    Kojima A, Kawakami K, Kobayashi N, Kobayashi K, Matsui TE, Uemoto K, Gu Y, Narita TJ, Kugawa M, Fukuda M et al.. Universal pipeline for high-resolution GPCR structure determination. (2026)  Nat Struct Mol Biol, 33 (9): 1393-1405. [PMID:42665663]

  • Tabula Sapiens 2.0: A comprehensive transcriptomic atlas of human cell types.
    Tabula Sapiens Consortium. Electronic address: steve@quake-lab.org, Tabula Sapiens Consortium. Tabula Sapiens 2.0: A comprehensive transcriptomic atlas of human cell types. (2026)  Cell, [Epub ahead of print]. [PMID:42685689]

  • A framework for understanding post-translational modifications of metabolic origin.
    Zhou YF, Zhang L, Udayanga DMN, Sharifi N, Wang ZA. A framework for understanding post-translational modifications of metabolic origin. (2026)  Trends Biochem Sci, [Epub ahead of print]. [PMID:42697755]

  • August 2026


  • The hallmarks of skeletal muscle health.
    Vainshtein A, Blaauw B, De Bock K, Munoz-Canoves P, Olson EN, Ottenheijm CAC, Richter EA, Ruas JL, Schaffer L, Spiegelman B et al.. The hallmarks of skeletal muscle health. (2026)  Nat Metab, [Epub ahead of print]. [PMID:42624901]

  • Multi-organ proteomic atlas of obesity regression in male mice.
    Boel F, Klinggaard EG, Akimov V, Hansen D, Uthpala ML, Maniyadath B, Fuglsang FR, Avellí MP, Rasmussen S, Ravnskjær K et al.. Multi-organ proteomic atlas of obesity regression in male mice. (2026)  Nat Metab, [Epub ahead of print]. [PMID:42629502]

  • Succinate drives macrophage inflammation by promoting GPR91 mitochondrial signaling in rheumatoid arthritis.
    Zhang W, Wang L, Zhao Y, Mu Y, Qiu L, Feng X, Wang Y, Zhao J, Chang Y, Wei W et al.. Succinate drives macrophage inflammation by promoting GPR91 mitochondrial signaling in rheumatoid arthritis. (2026)  Sci Transl Med, 18 (862): eaea8468. [PMID:42585294]

  • Urea transporter B-mediated urea uptake-induced protein carbamylation in platelets underlies bleeding in chronic kidney disease.
    Qiu Z, Xiong F, Wang Z, Zhao Y, Gao S, Zhang X, Chen Y, Liu Z, Li R, Cao L et al.. Urea transporter B-mediated urea uptake-induced protein carbamylation in platelets underlies bleeding in chronic kidney disease. (2026)  Sci Transl Med, 18 (863): eaed4678. [PMID:42616841]

  • Regulation of the Mineralocorticoid Receptor in Physiology and Disease.
    Young MJ, Fuller PJ, Meijer OC, Cole TJ, Kanki M, Yang J, Ho QV, Karthigan N, Heanue S. Regulation of the Mineralocorticoid Receptor in Physiology and Disease. (2026)  Pharmacol Rev, [Epub ahead of print]. DOI: 10.1016/j.pharmr.2026.100156

  • Promiscuous binding of CXC chemokines to ORF74 receptors enables immunotoxin approaches in Gammaherpesvirus models.
    Kildedal DF, Winther AN, Kledal TN, Jeppesen MG, Rosenkilde MM, Drzazga AK. Promiscuous binding of CXC chemokines to ORF74 receptors enables immunotoxin approaches in Gammaherpesvirus models. (2026)  Biochem Pharmacol, 253 (Pt 1): 118280 [Epub ahead of print]. [PMID:42492765]

  • Identification of CXCL13 as an agonist and CXCL11 as an inverse agonist for the viral G protein-coupled receptor ORF74.
    Kong Q, Van Bosstraeten B, De Jonghe S, Schols D, Van Loy T. Identification of CXCL13 as an agonist and CXCL11 as an inverse agonist for the viral G protein-coupled receptor ORF74. (2026)  Biochem Pharmacol, 253 (Pt 1): 118313 [Epub ahead of print]. [PMID:42556478]

  • Adaptive variation in butyrylcholinesterase-influenced lipid metabolism during horse domestication.
    Zhang Y, Liu X, Wang X, Yu Y, Jia Y, Pu Y, Ma Y, Orlando L, Jiang L. Adaptive variation in butyrylcholinesterase-influenced lipid metabolism during horse domestication. (2026)  Cell Rep, 45 (9): 117879 [Epub ahead of print]. [PMID:42623242]

  • Structural basis for substrate recognition and inhibition of human glucose-6-phosphate transporter SLC37A4.
    Li H, Peng X, Huang Y, Wu W, Li N, Cheng Z, Wei X. Structural basis for substrate recognition and inhibition of human glucose-6-phosphate transporter SLC37A4. (2026)  PLoS Biol, 24 (7): e3003833. [PMID:42520004]

  • SLC25A3 exports mitochondrial copper to metalate cytochrome c oxidase and prevent cuproptosis.
    Zulkifli M, Farid I, Oldfather LE, Shanbhag VC, Leary SC, Petris MJ, Cobine PA, Gohil VM. SLC25A3 exports mitochondrial copper to metalate cytochrome c oxidase and prevent cuproptosis. (2026)  Proc Natl Acad Sci U S A, 123 (25): e2612098123. [PMID:42308035]

  • SLC11A2 withholds divalent metals from Salmonella in the gut epithelium.
    Norberg ES, Westerman TL, Cruz E, Bushman SD, Salogiannis J, Skaar EP, Elfenbein JR, Knodler LA. SLC11A2 withholds divalent metals from Salmonella in the gut epithelium. (2026)  Proc Natl Acad Sci U S A, 123 (26): e2532675123. [PMID:42330289]

  • Does SLC17A9 (VNUT) function as a stand-alone nucleotide and/or phosphate transporter?.
    Struck J, Malviya V, Ganzella M, Acharya A, Barg-Kues B, Sambandan S, Ahnert-Hilger G, Jahn R. Does SLC17A9 (VNUT) function as a stand-alone nucleotide and/or phosphate transporter?. (2026)  J Biol Chem,: 113360 [Epub ahead of print]. [PMID:42486262]

  • SLC39A11 mediates intracellular manganese partitioning and adaptive iron transport.
    Cui Y, Du F, Wang J, Zhou B. SLC39A11 mediates intracellular manganese partitioning and adaptive iron transport. (2026)  Cell Rep, 45 (8): 117781 [Epub ahead of print]. [PMID:42531133]

  • July 2026


  • Recent advances in Alzheimer's disease: From molecular mechanisms to therapeutic strategies.
    Rudman MD, Ulrich JD, Holtzman DM. Recent advances in Alzheimer's disease: From molecular mechanisms to therapeutic strategies. (2026)  Cell, 189 (14): 4193-4224. [PMID:42425064]

  • Peptide ligand discovery of G protein-coupled receptors.
    Hermes J, Matic M, Yeung HY, Jiang Q, Urvas L, Korchevaya E, Stepniewski T, Murza A, Selent J, Freissmuth M et al.. Peptide ligand discovery of G protein-coupled receptors. (2026)  Nat. Rev. Methods Primers, 6 (52). DOI: 10.1038/s43586-026-00503-5

  • Evolution- and structure-guided redesign of the Stachel motif yields soluble and potent modulators of adhesion GPCRs.
    Useini A, Feng Y, Kaczmarek I, Künze G, Thor D, Schöneberg T. Evolution- and structure-guided redesign of the Stachel motif yields soluble and potent modulators of adhesion GPCRs. (2026)  J Biol Chem,: 113323 [Epub ahead of print]. [PMID:42442496]

  • Discovery of VU6081679, a Novel Positive Allosteric Modulator of Metabotropic Glutamate Receptor 8 with Efficacy in a Preclinical Model of Parkinson's Disease.
    Richardson AE, Ferranti AS, Peng L, Lei X, Han A, Qi A, Rodriguez AL, Chang S, Sant S, Zagol-Ikapitte I et al.. Discovery of VU6081679, a Novel Positive Allosteric Modulator of Metabotropic Glutamate Receptor 8 with Efficacy in a Preclinical Model of Parkinson's Disease. (2026)  ACS Chem Neurosci, [Epub ahead of print]. [PMID:42460925]

  • Library Docking for Cannabinoid-2 Receptor Ligands.
    Rachman MM, Iliopoulos-Tsoutsouvas C, Sacco MD, Xu X, Wu CG, Santos E, Glenn IS, Paris L, Cahill MK, Ganapathy S et al.. Library Docking for Cannabinoid-2 Receptor Ligands. (2026)  J Med Chem, 69 (14): 17038-17053. [PMID:42397716]

  • June 2026


  • Comprehensive profiling of clinically approved kinase inhibitors reveals mutation-specific inhibitors and opportunities for drug repurposing
    Chan M, Ma H, Subbiah V, Gujral TS. Mutation-centric kinase drug repurposing for rare cancers. (2026)  Nat Rev Cancer, [Epub ahead of print]. [PMID:42225836]
    Saifudeen M, Zhu S, Liang S, Eason M, Goupil A, Mische DF, Loch CM, Ma H, Chan M, Gujral TS. Comprehensive profiling of clinically approved kinase inhibitors reveals mutation-specific inhibitors and opportunities for drug repurposing. (2026)  Nat Biotechnol, [Epub ahead of print]. [PMID:42010121]
    KIRHub: Kinase Inhibitor Repurposing Hub.  https://kirhub.fredhutch.org/

  • Towards mRNA therapeutics 2.0.
    Chien KR, Foo KS, Witman N. Towards mRNA therapeutics 2.0. (2026)  Nat Rev Drug Discov, [Epub ahead of print]. [PMID:42236989]

  • A natural depsipeptide antibiotic binds the E-site of the bacterial ribosome.
    Kaur M, Travin DY, Berger MJ, Jangra M, Morici M, Safdari HA, Klepacki D, Wang W, Cook M, Chou S et al.. A natural depsipeptide antibiotic binds the E-site of the bacterial ribosome. (2026)  Nature, [Epub ahead of print]. [PMID:42236948]

  • Deorphanisation and functional characterisation of OATP5A1 as transport protein for amino acids and vitamins.
    Kohlmann E, Schmid NK, Gessner A, Fromm MF, König J. Deorphanisation and functional characterisation of OATP5A1 as transport protein for amino acids and vitamins. (2026)  Cell Mol Biol Lett, 31 (1). [PMID:42231149]

  • Challenges and opportunities in RNA-centered therapeutics.
    Song Y. Challenges and opportunities in RNA-centered therapeutics. (2026)  Nat Chem Biol, 22 (6): 847-854. [PMID:42225945]

  • May 2026


  • International Union of Basic and Clinical Pharmacology. CXXII. Applying an objective evaluation to the status of class A orphan G protein-coupled receptors.
    Alexander SPH, Bennett KA, Brown AJ, Glass M, Gloriam DE, Hanson J, Insel PA, Kelly E, Langmead CJ, Martemyanov KA et al.. International Union of Basic and Clinical Pharmacology. CXXII. Applying an objective evaluation to the status of class A orphan G protein-coupled receptors. (2026)  Pharmacol Rev, 78 (4): 100141. DOI: 10.1016/j.pharmr.2026.100141 [PMID:42269381]

  • First PROTAC gains FDA approval, bolstering targeted protein degradation and induced proximity ambitions.
    Mullard A. First PROTAC gains FDA approval, bolstering targeted protein degradation and induced proximity ambitions. (2026)  Nat Rev Drug Discov, 25 (6): 411. [PMID:42103863]

  • Posttranslational modifications remodel proteome-wide ligandability.
    Li W, Wei Q, Llanos M, Gathmann C, Governa P, Chiu TY, Wozniak JM, Jadhav AM, Holcomb M, Cravatt J et al.. Posttranslational modifications remodel proteome-wide ligandability. (2026)  Nat Chem Biol, [Epub ahead of print]. [PMID:42086908]

  • Metformin inhibits mitochondrial complex I in intestinal epithelium to promote glycaemic control.
    Sebo ZL, Chakrabarty RP, Grant RA, D'Alessandro KB, Koss AR, Blum JLE, Davidson SM, Reczek CR, Chandel NS. Metformin inhibits mitochondrial complex I in intestinal epithelium to promote glycaemic control. (2026)  Nat Metab, [Epub ahead of print]. [PMID:42103929]

  • Phasing out animal research prematurely will maintain gender inequities in medicine.
    Kovlyagina I, Jaric I. Phasing out animal research prematurely will maintain gender inequities in medicine. (2026)  Nat Neurosci, 29 (6): 1269-1270. [PMID:42082817]

  • Structural determinants of ligand response specificity in the mast cell activating GPCR, MRGPRX2.
    Adeosun AAR, Agosto MA, Lichtarge O, Wensel TG. Structural determinants of ligand response specificity in the mast cell activating GPCR, MRGPRX2. (2026)  J Biol Chem, 302 (6): 113132 [Epub ahead of print]. [PMID:42107641]

  • Decoding the structure of GPR151 via NELiS.
    Wang Y, Fan L, Song Q, Li Y, Jin J, Zhao Q, Gu W, Shi X, Li D, Cong Y et al.. Decoding the structure of GPR151 via NELiS. (2026)  Proc Natl Acad Sci U S A, 123 (19): e2534234123. [PMID:42085164]

  • Target identification and assessment in the era of AI.
    Pun FW, Podolskiy D, Izumchenko E, Mortlock A, Oprea TI, Scheibye-Knudsen M, Fortney K, Morgen E, Ren F, Zhavoronkov A. Target identification and assessment in the era of AI. (2026)  Nat Rev Drug Discov, [Epub ahead of print]. [PMID:42009769]

  • Multi-cohort proteogenomic analyses reveal genetic effects across the proteome and diseasome.
    Koprulu M, Smith-Byrne K, Ferolito BR, Macdonald-Dunlop E, Luan J, Hedman ÅK, Ogamba CF, Kuliesius J, Repetto L, Ramisch A et al.. Multi-cohort proteogenomic analyses reveal genetic effects across the proteome and diseasome. (2026)  Cell, 189 (11): 3339-3357.e11. [PMID:42097137]

  • Genetic predictors of GLP1 receptor agonist weight loss and side effects
    Loos RJF. Genetics reveal why people respond differently to GLP-1 weight-loss drugs. (2026)  Nature, [Epub ahead of print]. [PMID:41951816]
    Su QJ, Ashenhurst JR, Xu W, Tran V, Ryanne Wu R, Weldon CH, Shi J, Hicks B, 23andMe Research Team, Abul-Husn NS et al.. Genetic predictors of GLP1 receptor agonist weight loss and side effects. (2026)  Nature, 653 (8115): 770-775. [PMID:41951734]

  • Development of a clinically viable MRGPRX4 inverse agonist for cholestatic itch treatment.
    Yang J, Shen R, Wang C, Zhu W, Ke H, Fan J, Zhang M, Liu Y, Li S, Li G et al.. Development of a clinically viable MRGPRX4 inverse agonist for cholestatic itch treatment. (2026)  Nat Chem Biol, [Epub ahead of print]. [PMID:41957282]

  • Mitochondrial remodeling in skeletal muscle underlies exercise-induced reversal of age-associated functional decline in mice and humans.
    García-Domínguez E, García-Domínguez C, Cabrera-Alarcón JL, Muñoz-Hernández MDM, Hernansanz-Agustín P, Curtabbi A, Domenech-Fernandez J, Calvo E, Vázquez J, Serrano AL et al.. Mitochondrial remodeling in skeletal muscle underlies exercise-induced reversal of age-associated functional decline in mice and humans. (2026)  Proc Natl Acad Sci U S A, 123 (14): e2508286123. [PMID:41911459]

  • Dynamic mechanism for subtype selectivity of endocannabinoids.
    Dutta S, Zhao L, Shukla D. Dynamic mechanism for subtype selectivity of endocannabinoids. (2026)  J Biol Chem, 302 (6): 111434 [Epub ahead of print]. [PMID:41962866]

  • Lysosomal Membrane Proteins: Key Regulators of Glucose Metabolism and Its Associated Diseases.
    Xu J, Jin Y, Liu S, Dong S, Xiong C, Zhang R, Pei W, Wu X, Wang L, Gao J. Lysosomal Membrane Proteins: Key Regulators of Glucose Metabolism and Its Associated Diseases. (2026)  FASEB J, 40 (8): e71717. [PMID:41961021]

  • iNOS modulates inflammatory responses in an NO-independent manner through direct interaction with IRG1 in mitochondria
    Diotallevi M, Outeiral C, Patel P, Purvis GSD, Chuaiphichai S, Nicol T, Ayaz F, Nissley DA, Krasnoselska GO, Hester S et al.. iNOS modulates inflammatory responses in an NO-independent manner through direct interaction with IRG1 in mitochondria. (2026)  Nat Metab, 8 (4): 855-868. [PMID:41963607]
    Paulenda T, Artyomov MN. Mitochondrial iNOS blocks itaconate production by interacting with IRG1. (2026)  Nat Metab, 8 (4): 768-769. [PMID:41963606]

  • April 2026


  • Whole-body molecular and cellular mapping of the laboratory mouse.
    Clevenger MH, Cipurko D, Patil A, Li B, Takahama M, Mei L, Plaster M, Richey G, Kawamoto T, Bao F et al.. Whole-body molecular and cellular mapping of the laboratory mouse. (2026)  Cell, 189 (11): 3481-3498.e24. [PMID:41903540]

  • Structural basis for pH-responsive amino acid transport via SLC7A4.
    Kolokouris D, Bothra A, Kato T, Zeng YC, Lichtinger S, Parker JL, Biggin PC, Newstead S. Structural basis for pH-responsive amino acid transport via SLC7A4. (2026)  Nat Commun, [Epub ahead of print]. [PMID:41904136]

  • GLASS2: An Updated Database for Comprehensive Experimentally Validated GPCR-ligand Associations.
    Xu F, Zheng X, Wang W, Lu H, Yang Z, Meng D, Long J, Zhang Y. GLASS2: An Updated Database for Comprehensive Experimentally Validated GPCR-ligand Associations. (2026)  J Mol Biol,: 169758 [Epub ahead of print]. [PMID:41850519]

  • What's in a Name? Upgrading Virus Species Nomenclature.
    Zerbini FM, Kuhn JH. What's in a Name? Upgrading Virus Species Nomenclature. (2026)  Annu Rev Virol, [Epub ahead of print]. [PMID:41871308]

  • ATP13A2 restrains macrophage NLRP3 inflammasome activation to repress neurodegeneration via modulating mitochondrial homeostasis.
    Zou Z, Zhou J, Lu Y, Huang Y, Zhou L, Wang X, Chen J, Tian H, Ge X, Guo C et al.. ATP13A2 restrains macrophage NLRP3 inflammasome activation to repress neurodegeneration via modulating mitochondrial homeostasis. (2026)  Proc Natl Acad Sci U S A, 123 (12): e2534066123. [PMID:41843675]

  • Gut microbe-derived N-acyl serinol lipids shape host postprandial metabolic homeostasis.
    Dutta S, Mahen KK, Massey WJ, Varadharajan V, Burrows AC, Horak 3rd AJ, Mrdjen M, Mouannes N, Orabi D, Osborn LJ et al.. Gut microbe-derived N-acyl serinol lipids shape host postprandial metabolic homeostasis. (2026)  Proc Natl Acad Sci U S A, 123 (12): e2517314123. [PMID:41855263]

  • Pregnane X receptor in disease: From xenobiotic sensor to therapeutic target.
    Gao Y, Yu Q, Zhang L, He Z, Li X, Ou W, Wu X, Fan S, Bi H. Pregnane X receptor in disease: From xenobiotic sensor to therapeutic target. (2026)  Pharmacol Rev, 78 (3): 100133. [PMID:42013674]

  • Mitochondrial lactate venting limits oxidative stress.
    Rauseo D, Contreras-Baeza Y, Salazar M, Galarza AJ, Holtheuer-Gallardo S, Faurand H, Cárcamo-Lemus N, Suárez R, Asenjo JL, von Faber-Castell A et al.. Mitochondrial lactate venting limits oxidative stress. (2026)  Cell Metab, 38 (6): 1130-1140.e6. [PMID:41881014]

  • Exercise as a therapeutic intervention for long-lasting and chronic diseases.
    Febbraio MA, Pedersen BK. Exercise as a therapeutic intervention for long-lasting and chronic diseases. (2026)  Cell Metab, [Epub ahead of print]. [PMID:41875883]

  • Lysosomal salvage of neuronal lipids enables glial infiltration of synaptic regions.
    Theisen EK, Rivas-Serna IM, Cheng P, Lee RJ, Thomas CI, Darehshouri A, Jay TR, Kunduri G, Nguyen TT, Mazurak V et al.. Lysosomal salvage of neuronal lipids enables glial infiltration of synaptic regions. (2026)  Neuron, [Epub ahead of print]. [PMID:41887214]

  • Advances in understanding aryl hydrocarbon receptor structure, function, and modulation.
    Shang Q, Khorasanizadeh S, Diao X, Rastinejad F, Wu D. Advances in understanding aryl hydrocarbon receptor structure, function, and modulation. (2026)  Trends Biochem Sci, [Epub ahead of print]. [PMID:41896063]

  • March 2026


  • International Union of Basic and Clinical Pharmacology. CXXI. Apelin receptor pharmacology in the human cardiovascular system and emerging clinical applications.
    Davenport AP, Williams TL, Nyimanu D, Macrae RGC, Kuc RE, Chapman FA, Yang P, Dhaun N, Maguire JJ. International Union of Basic and Clinical Pharmacology. CXXI. Apelin receptor pharmacology in the human cardiovascular system and emerging clinical applications. (2026)  Pharmacol Rev, 78 (3): 100130 [Epub ahead of print]. [PMID:41895070]

  • The dynamic basis of G-protein recognition and activation by a GPCR.
    Kobayashi K, Kawakami K, Matsui TE, Yokoi S, Fukuda M, Narita TJ, Arai H, Tambo M, Sumikama T, Tatsumi M et al.. The dynamic basis of G-protein recognition and activation by a GPCR. (2026)  Nature, 652 (8110): 812-821. [PMID:41813902]

  • Snapshots of the dynamic basis of NTSR1 G protein subtype promiscuity.
    Vo AA, Modak A, Lu S, Blanchard SC, Lambert NA, Robertson MJ. Snapshots of the dynamic basis of NTSR1 G protein subtype promiscuity. (2026)  Nature, 652 (8110): 803-811. [PMID:41813894]

  • Organization of neuropeptide systems in the human brain.
    Ceballos EG, Farahani A, Liu ZQ, Milisav F, Hansen JY, Dagher A, Misic B. Organization of neuropeptide systems in the human brain. (2026)  Nat Neurosci, 29 (5): 1212-1224. [PMID:41845130]

  • The role of the tryptophan-rich allosteric network and sodium egress in GPCR activation.
    Qi Z, Tran DP, Tučs A, Thiara R, Picard LP, Tsuda K, Pandey A, Sljoka A, Kitao A, Prosser RS. The role of the tryptophan-rich allosteric network and sodium egress in GPCR activation. (2026)  Proc Natl Acad Sci U S A, 123 (10): e2525502123. [PMID:41774790]

  • SV2A PET reveals synaptic density loss in experimental autoimmune encephalomyelitis and in a pilot multiple sclerosis study.
    Chia PHJ, Toyonaga T, Tong J, Le H, Dias M, Boyle AJ, Raymond R, Longbrake EE, Huang Y, Carson RE et al.. SV2A PET reveals synaptic density loss in experimental autoimmune encephalomyelitis and in a pilot multiple sclerosis study. (2026)  Proc Natl Acad Sci U S A, 123 (10): e2517709123. [PMID:41774796]

  • The Human Organ Atlas.
    Walsh CL, Brunet J, Stansby D, Gaisné G, Zhou Y, Ackermann M, Bellier A, Berruyer C, Bocciarelli A, Bodin M. The Human Organ Atlas. (2026)  Sci. Adv., 12 (11) [Epub ahead of print]. DOI: 10.1126/sciadv.adz2240

  • Autophagolysosomal exocytosis inverts Src kinase onto the cell surface in cancer
    Delaveris CS, Loudermilk RP, Pandey A, Remesh SG, Peters-Clarke TM, Ganjave SD, Dougherty WJN, Delavan HM, Wang C, Ling J et al.. Autophagolysosomal exocytosis inverts Src kinase onto the cell surface in cancer. (2026)  Science, 391 (6790): eaec1778. [PMID:41818370]
    Pfannenstein A, Meyer T. Extending the reach of a classic oncogene. (2026)  Science, 391 (6790): 1103-1104. [PMID:41818382]

  • FDA black box warnings: characteristics of drug classes and adverse effects.
    Bindel LJ, Seifert R. FDA black box warnings: characteristics of drug classes and adverse effects. (2026)  J. Pharmacol. Exp. Ther., [Epub ahead of print]. DOI: 10.1016/j.jpet.2026.104317

  • d-lactate drives lysine d-lactylation to regulate metabolism in Escherichia coli.
    Zhang J, Zang Y, Yu Z, Zhao F, Wu J, Wang Y, Wang A, Zhai G, Han Y, Chen C et al.. d-lactate drives lysine d-lactylation to regulate metabolism in Escherichia coli. (2026)  J Biol Chem, 302 (5): 111374. [PMID:41850399]

  • Activation dynamics of a water-soluble human mu-opioid receptor.
    Agyemang E, Van Wirt R, Walls C, Joseph TT, Tiruvadi-Krishnan S, Grothusen J, Zhang Q, Hicks A, Leite W, Osti NC et al.. Activation dynamics of a water-soluble human mu-opioid receptor. (2026)  J Biol Chem, 302 (5): 111393. [PMID:41866033]

  • Targeting protein-protein interactions with reversible covalent modalities: Non-cysteine chemistries.
    Basu R, Fletcher S. Targeting protein-protein interactions with reversible covalent modalities: Non-cysteine chemistries. (2026)  Br J Pharmacol, [Epub ahead of print]. [PMID:41834613]

  • Effects of N-glycosylation on the transport kinetics of organic anion transporting polypeptide (OATP) 1B1.
    Tanino M, Tsujii K, Kataoka H, Takahashi R, Imaoka A, Akiyoshi T, Ohtani H. Effects of N-glycosylation on the transport kinetics of organic anion transporting polypeptide (OATP) 1B1. (2026)  Biochim Biophys Acta Biomembr, 1868 (2): 184509. [PMID:41707902]

  • Optimization of α-Fluoro, β-Heteroaryl Acrylamide Warheads for KRASG12C Active-State Inhibition.
    Condakes ML, Civiello RL, Venables BL, Danahy DB, Moore RR, Balachander SB, Chourb LS, Downes DP, Drexler DM, Dzhekieva L et al.. Optimization of α-Fluoro, β-Heteroaryl Acrylamide Warheads for KRASG12C Active-State Inhibition. (2026)  J Med Chem, 69 (5): 5935-5943. [PMID:41770619]

  • Optimization of Covalent Warhead Trajectory for KRASG12C Active-State Inhibition.
    Condakes ML, Civiello RL, Lakkaraju SK, Sloane JL, Chourb LS, Downes DP, Drexler DM, Dzhekieva L, El-Samin M, Levins C et al.. Optimization of Covalent Warhead Trajectory for KRASG12C Active-State Inhibition. (2026)  J Med Chem, 69 (5): 5925-5934. [PMID:41769786]

  • Discovery and Optimization of a Potent, Efficacious, and Brain-Penetrant Inhibitor of KRAS G12C.
    Landry ML, Malhotra S, Beresini M, Chan C, Chan E, de la Cruz CC, Endres NF, Evangelista M, Gustafson A, Hu D et al.. Discovery and Optimization of a Potent, Efficacious, and Brain-Penetrant Inhibitor of KRAS G12C. (2026)  J Med Chem, [Epub ahead of print]. [PMID:41769711]

  • Discovery and Characterization of Divarasib (GDC-6036), a Potent Covalent Inhibitor of KRAS G12C.
    Endres NF, Do S, Mroue R, Terrett JA, Saabye M, Oh A, Hunsaker T, Chan E, Tran JC, Nguyen LK et al.. Discovery and Characterization of Divarasib (GDC-6036), a Potent Covalent Inhibitor of KRAS G12C. (2026)  J Med Chem, 69 (5): 5147-5165. DOI: 10.1021/acs.jmedchem.5c02272 [PMID:41766690]

  • Polypharmacology Browser PPB3: A Web-Based Deep Learning Tool for Target Prediction Using ChEMBL Data.
    Darsaraee M, Javor S, Reymond JL. Polypharmacology Browser PPB3: A Web-Based Deep Learning Tool for Target Prediction Using ChEMBL Data. (2026)  J Chem Inf Model, 66 (5): 2466-2473. [PMID:41721463]

  • SLC52A1 is a neofunctionalized primate urate transporter enabling intestinal urate secretion.
    Yamamoto S, Inoue K, Yasujima T, Takei H, Yamashiro T, Asai K, Matake I, Uchiyama S, Ohta K, Kishimoto H et al.. SLC52A1 is a neofunctionalized primate urate transporter enabling intestinal urate secretion. (2026)  J Biol Chem, 302 (4): 111310. [PMID:41759742]

  • Coffee and Tea Intake, Dementia Risk, and Cognitive Function.
    Zhang Y, Liu Y, Li Y, Li Y, Gu X, Kang JH, Eliassen AH, Wang M, Rimm EB, Willett WC et al.. Coffee and Tea Intake, Dementia Risk, and Cognitive Function. (2026)  JAMA, [Epub ahead of print]. [PMID:41661604]

  • RYK is a GPNMB receptor that drives MASH.
    Xi Y, Zeng W, Luo J, Zhou J, Wang L, Sun J, He Z, Li W, Zhu S, Qi W et al.. RYK is a GPNMB receptor that drives MASH. (2026)  Nature, 652 (8110): 703-711. [PMID:41708863]

  • Liver exerkine reverses aging- and Alzheimer's-related memory loss via vasculature.
    Bieri G, Pratt KJB, Fuseya Y, Aghayev T, Sucharov J, Horowitz AM, Philp AR, Fonseca-Valencia K, Chu R, Phan M et al.. Liver exerkine reverses aging- and Alzheimer's-related memory loss via vasculature. (2026)  Cell, 189 (5): 1499-1516.e25. [PMID:41713415]

  • OR7A10 GPCR engineering boosts CAR-NK therapy against solid tumours.
    Yang L, Renauer PA, Tang K, Saskin J, Zhou L, Zou C, Lee SH, Fox M, Johnson-Noya S, Weiss B et al.. OR7A10 GPCR engineering boosts CAR-NK therapy against solid tumours. (2026)  Nature, [Epub ahead of print]. [PMID:41741641]

  • Adhesion GPCR-induced ectocytosis mediates intercellular GPCR signal propagation.
    Huang G, Li N, Chen Y, Li X, Xu XZS, Xu C, Liu J. Adhesion GPCR-induced ectocytosis mediates intercellular GPCR signal propagation. (2026)  Nat Chem Biol, [Epub ahead of print]. [PMID:41688711]

  • A two-step clockwork mechanism opens a proteo-lipidic pore in PIEZO2.
    Li S, Wijerathne T, Bhatt A, Jiang W, Lacroix J, Han W, Luo YL. A two-step clockwork mechanism opens a proteo-lipidic pore in PIEZO2. (2026)  Nat Chem Biol, [Epub ahead of print]. [PMID:41703062]

  • Reimagining pharmacology education.
    Guilding C, Kelly-Laubscher R, Cunningham M, Dilles T, Kennedy D, Brinkman DJ, Eid AH, Quesnelle KM, Engels F, Maxwell S et al.. Reimagining pharmacology education. (2026)  Pharmacol. Rev., Epub ahead of print. DOI: 10.1016/j.pharmr.2026.100126

  • Sialylation in the Nervous System: Functions and Mechanisms.
    Koles K, Repnikova E, Novikov B, Panin V. Sialylation in the Nervous System: Functions and Mechanisms. (2026)  J Biol Chem,: 111288 [Epub ahead of print]. [PMID:41708000]

  • Pyruvate is a natural suppressor of interferon signaling by inducing STAT1 protein pyruvylation.
    Zuo Y, Wang Q, Tian W, Wang X, Zheng Z, He W, Zhang R, Zhao Q, Miao Y, Yuan Y et al.. Pyruvate is a natural suppressor of interferon signaling by inducing STAT1 protein pyruvylation. (2026)  Cell, 189 (7): 1975-1989.e19. [PMID:41763198]

  • MRAP2 potentiates GPCR signaling by conserved mechanisms that are disrupted by obesity-associated genetic variants.
    Jamaluddin A, Wyatt RA, Broichhagen J, Levitz J, Gorvin CM. MRAP2 potentiates GPCR signaling by conserved mechanisms that are disrupted by obesity-associated genetic variants. (2026)  Cell Rep, 45 (3): 117018. [PMID:41722048]

  • February 2026


  • A GPCR-G protein-β-arrestin megacomplex enabled by a versatile allosteric modulator.
    He G, Sun Q, Xu X, Kong F, Zhang S, Ye K, Sun X, Lin B, Chen X, Yan C et al.. A GPCR-G protein-β-arrestin megacomplex enabled by a versatile allosteric modulator. (2026)  Cell, 189 (5): 1434-1450.e22. [PMID:41605208]

  • Dual targeting of SLC25A51 and succinate dehydrogenase selectively depletes mitochondrial NAD+ to eradicate KRAS-driven AML.
    Jia A, Zhang X, Zhou JH, Ma Y, Wang J, Gong Y, Song W, Hu H, Yu Y, Yang H et al.. Dual targeting of SLC25A51 and succinate dehydrogenase selectively depletes mitochondrial NAD+ to eradicate KRAS-driven AML. (2026)  Cell Metab, [Epub ahead of print]. [PMID:41616775]

  • CLN3 mediates chloride efflux from lysosomes.
    Wang Y, Li K, Chen W, Chen C, Yong AJH, Zhang X, Tynan-La Fontaine M, Jan YN, Jan LY. CLN3 mediates chloride efflux from lysosomes. (2026)  Neuron, 114 (5): 868-883.e7. [PMID:41558486]

  • GPR39-mediated molecular signaling by bile acids.
    Huang Y, Zi Z, Xia C, Rao Y. GPR39-mediated molecular signaling by bile acids. (2026)  J Biol Chem, 302 (3): 111241. [PMID:41651415]

  • PtdIns(3,5)P2 is an endogenous ligand of STING in innate immune signalling.
    Tan JX, Lv B, Li J, Li T, Du F, Chen X, Zhang X, Bai XC, Chen ZJ. PtdIns(3,5)P2 is an endogenous ligand of STING in innate immune signalling. (2026)  Nature, [Epub ahead of print]. [PMID:41639454]

  • Regulation of STING activation by phosphoinositide and cholesterol.
    Li J, Tan JX, Chen ZJ, Zhang X, Bai XC. Regulation of STING activation by phosphoinositide and cholesterol. (2026)  Nature, 652 (8109): 499-507. [PMID:41639452]

  • SLC6A6 imports taurine into mitochondria to sustain mitochondrial translation and tumour growth.
    Li L, You J, Chai ZQ, Li X, Cai X, Wang L, Yang F, Zhu L, Mi W, Xia X et al.. SLC6A6 imports taurine into mitochondria to sustain mitochondrial translation and tumour growth. (2026)  Nat Metab, 8 (3): 704-721. [PMID:41652173]

  • RHOA controls oncogenic B cell receptor signaling in aggressive lymphoma.
    Jacobs AN, Jahn D, Beringer T, Wolf S, Krishnan RK, Engelke M, Häupl B, Münch S, Dienstbier N, Pape M et al.. RHOA controls oncogenic B cell receptor signaling in aggressive lymphoma. (2026)  Proc Natl Acad Sci U S A, 123 (5): e2534531123. [PMID:41591906]

  • Soluble adenylyl cyclase in nonmammalian sperm is directly controlled by pH, not by HCO3- or Ca2.
    Kendall O, Hoang OT, Wort JL, Hamzeh H, Körschen HG, Pascal R, Korsching K, Wu-Lu M, Bönigk W, Kambach C et al.. Soluble adenylyl cyclase in nonmammalian sperm is directly controlled by pH, not by HCO3- or Ca2. (2026)  Proc Natl Acad Sci U S A, 123 (5): e2505026123. [PMID:41591904]

  • Mechanistic insights into fatty acid odor detection mediated by class II olfactory receptors.
    Han X, Zhang MH, Rong NK, Zhu KK, Pei Y, Ge XY, Liu Q, Lu H, Liu J, Zhang LJ et al.. Mechanistic insights into fatty acid odor detection mediated by class II olfactory receptors. (2026)  Cell, 189 (5): 1465-1480.e19. [PMID:41570821]

  • Structural decoding of reversible covalent linkage of odorants in human olfactory receptor OR6A2.
    Wang T, Wu Y, Wang L, Li S, Zhao F, Wu L, Liu Y, Qin J, Tan Q, Liu J et al.. Structural decoding of reversible covalent linkage of odorants in human olfactory receptor OR6A2. (2026)  Cell, 189 (5): 1451-1464.e27. [PMID:41570822]

  • Identification of Or5v1/Olfr110 as an oxylipin receptor and anti-obesity target.
    Ge XY, Cheng J, Zhang LJ, Guo LL, Xiang R, Lu Y, Ning SL, Wang KY, Zhu KK, Gao MX et al.. Identification of Or5v1/Olfr110 as an oxylipin receptor and anti-obesity target. (2026)  Cell, 189 (5): 1481-1498.e22. [PMID:41570820]

  • January 2026


  • 2025 FDA approvals.
    Mullard A. 2025 FDA approvals. (2026)  Nat Rev Drug Discov, 25 (2): 81-87. [PMID:41482567]

  • Non-equilibrium snapshots of ligand efficacy at the μ-opioid receptor.
    Robertson MJ, Modak A, Papasergi-Scott MM, Hu M, Peroto MC, Varga BR, Majumdar S, Kalathur R, Blanchard SC, Skiniotis G. Non-equilibrium snapshots of ligand efficacy at the μ-opioid receptor. (2026)  Nature, 652 (8110): 794-802. [PMID:41430437]

  • The Role of Intrinsically Disordered Domains in Regulating G Protein-Coupled Receptor Signaling.
    Xu J, Qiu R, Garces AM, Hübner H, Xu X, Hao C, Weikert D, Gmeiner P, Lerch MT, Kobilka BK. The Role of Intrinsically Disordered Domains in Regulating G Protein-Coupled Receptor Signaling. (2026)  J Am Chem Soc, 148 (1): 1430-1443. [PMID:41454868]

  • Structures of G-protein coupled receptor HCAR3 in complex with selective agonists reveal the basis for ligand recognition and selectivity.
    Ye F, Zhang Z, Zhang B, Li X, Deng J, Miao Q, Ning P, Chi Y, Chen G, Wu Z et al.. Structures of G-protein coupled receptor HCAR3 in complex with selective agonists reveal the basis for ligand recognition and selectivity. (2025)  PLoS Biol, 23 (12): e3003480. [PMID:41359625]

  • GPNMB is a biomarker for lysosomal dysfunction and is secreted via LRRK2-modulated lysosomal exocytosis.
    Bogacki EC, Parfitt GM, Cunha A, Longmore G, Wray S, Lewis PA, Herbst S. GPNMB is a biomarker for lysosomal dysfunction and is secreted via LRRK2-modulated lysosomal exocytosis. (2025)  Sci Adv, 11 (51): eadv1434. [PMID:41406229]

  • VNUT-mediated ATP release suppresses T helper 1 (TH1) cell differentiation via the P2X7R-JNK-FOXO3a-Eomes signaling cascade.
    Wu B, Sheng L, Feng Z, Wang X, Chen L. VNUT-mediated ATP release suppresses T helper 1 (TH1) cell differentiation via the P2X7R-JNK-FOXO3a-Eomes signaling cascade. (2025)  Sci Adv, 11 (51): eadz7600. [PMID:41417887]

  • AQP5: A functional gastric cancer stem cell marker in mouse and human tumors.
    Lim HYG, Yada S, Murakami K, Lee BTK, Sagiraju S, Phuah P, Chen TC, Alvina FB, Tan SH, Kaslikar KK et al.. AQP5: A functional gastric cancer stem cell marker in mouse and human tumors. (2025)  Science, 390 (6779): eadr2428. [PMID:41411445]

  • SLC16A3 as a novel therapeutic target for overcoming radioresistance and chemoresistance in lung cancer.
    Kim HM, Bae MJ, Lee CG, Jo WS, Kye YU, Kim H, Kang YR, Han SJ, Hwang SG, Baek JH. SLC16A3 as a novel therapeutic target for overcoming radioresistance and chemoresistance in lung cancer. (2026)  Biochem Biophys Res Commun, 797: 153204. [PMID:41475270]

  • SigmaR1 is an auxiliary translocon factor with lipid-binding activity that regulates protein and lipid droplet homeostasis.
    Hu X, Zhou T, Cui T, Du Y, Song C, Chang W, Xiong J, Qin J, Deng L, Ji WK. SigmaR1 is an auxiliary translocon factor with lipid-binding activity that regulates protein and lipid droplet homeostasis. (2025)  Nat Commun, 17 (1): 1415. [PMID:41476177]

  • CD Molecules Nomenclature 2025: Antibody Validation and Expression Profiling of Immune System G Protein-Coupled Receptors.
    Fernández-Calles J, Kužílková D, Hedin F, Bakardjieva-Mihaylova V, Škvárová Kramarzová K, van Zelm MC, Cosma A, Kalina T, Engel P, Human Cell Differentiation Molecules (HCDM) organization. CD Molecules Nomenclature 2025: Antibody Validation and Expression Profiling of Immune System G Protein-Coupled Receptors. (2025)  Eur J Immunol, 55 (12): e70099. [PMID:41420480]

  • Mitochondrial control of fuel switching via carnitine biosynthesis.
    Auger C, Nishida H, Yuan B, Silva GM, Fujimoto M, Li M, Katoh D, Wang D, Granath-Panelo M, Shin J et al.. Mitochondrial control of fuel switching via carnitine biosynthesis. (2026)  Science, 391 (6786): eady5532. [PMID:41505503]

  • L-lactic acid enhances type I interferon immune response and inhibits virus infection by promoting IRF9 L-lactylation.
    Miao Y, Cui Q, Zhang T, Zhang R, Zhao Q, Zhou H, Zuo Y, Wang Q, Zhang Y, Zheng Z et al.. L-lactic acid enhances type I interferon immune response and inhibits virus infection by promoting IRF9 L-lactylation. (2026)  Proc Natl Acad Sci U S A, 123 (1): e2521070123. [PMID:41481472]

  • Oligomerization of Transmembrane Adenylyl Cyclase Isoforms.
    Arya S, Tesmer JGJ, Dessauer CW, Watts VJ. Oligomerization of Transmembrane Adenylyl Cyclase Isoforms. (2026)  Mol. Pharmacol., Epub ahead of print. DOI: 10.1016/j.molpha.2026.100101

  • Obesity impairs gut repair via AFABP-mediated iron overload in intestinal stem cells.
    Liu Z, Chen Y, Yan J, Yuan Y, Wan Q, Zhao R, Fu F, Fan X, Deng Y, Guo X et al.. Obesity impairs gut repair via AFABP-mediated iron overload in intestinal stem cells. (2026)  Nat Metab, 8 (1): 74-95. [PMID:41507665]

  • Photo-cross-linking-assisted deorphanization deciphers GPR50-L-LEN pairing in metabolism.
    Wu R, Li N, Wen Z, Wang Y, Li S, Zhou H, Huang Y, Xie X, Zhao X, Wang X et al.. Photo-cross-linking-assisted deorphanization deciphers GPR50-L-LEN pairing in metabolism. (2026)  Nat Chem Biol, [Epub ahead of print]. [PMID:41495223]

  • The 2025 Report on the Human Proteome from the HUPO Human Proteome Project.
    Deutsch EW, Lindskog C, Budnik B, Ctortecka C, Guo T, Pineau C, Zhang G, Andken M, Zheng C, Sun Z et al.. The 2025 Report on the Human Proteome from the HUPO Human Proteome Project. (2026)  J Proteome Res, 25 (2): 539-555. [PMID:41490290]

  • December 2025


  • SLC45A4 encodes a peroxisomal putrescine transporter that promotes GABA de novo synthesis.
    Colson C, Wang Y, Atherton J, Dahiya NR, Kharaghani D, Su X. SLC45A4 encodes a peroxisomal putrescine transporter that promotes GABA de novo synthesis. (2025)  Nat Commun, 16 (1): 10198. [PMID:41266324]

  • Structural basis of glucose-6-phosphate transport by human SLC37A2.
    Lai Q, Xu M, Gao Y, Yang Z, Sun L, Liu X. Structural basis of glucose-6-phosphate transport by human SLC37A2. (2026)  Nat Struct Mol Biol, 33 (1): 112-122. [PMID:41225050]

  • Structural basis of G6P/Pi transport and inhibition in SLC37A4.
    Zhou D, Zhang Y, Chen N, Huang S, Song C, Zhang Z. Structural basis of G6P/Pi transport and inhibition in SLC37A4. (2026)  Nat Struct Mol Biol, 33 (1): 123-133. [PMID:41225049]

  • Impaired cAMP-PKA-CREB1 signalling drives mitochondrial dysfunction in skeletal muscle during cancer cachexia.
    Angelino E, Bodo L, Sartori R, Malacarne V, D'Anna B, Formaggio N, Barua S, Raiteri T, Lauria A, Reano S et al.. Impaired cAMP-PKA-CREB1 signalling drives mitochondrial dysfunction in skeletal muscle during cancer cachexia. (2025)  Nat Metab, 7 (12): 2548-2570. [PMID:41224958]

  • PIEZO1 gain-of-function mutation drives cardiomyopathy by disrupting myocardial lipid homeostasis besides iron overload.
    Fan C, Du H, Sun S, Lu H, Wang Y, Lu F, Wang Q, Zhang C, Xue L, Pan C et al.. PIEZO1 gain-of-function mutation drives cardiomyopathy by disrupting myocardial lipid homeostasis besides iron overload. (2025)  Sci Adv, 11 (46): eady9242. [PMID:41237237]

  • 'A sigh of relief': New malaria drug succeeds in clinical trial as existing treatments falter.
    Kupferschmidt K. 'A sigh of relief': New malaria drug succeeds in clinical trial as existing treatments falter. (2025)  Science, 390 (6775): 771-772. [PMID:41264705]

  • Intestinal TGR5-targeted carrier-drug conjugate improves glycemic control in mice and pigs.
    Zhang Y, Huang H, Wang Y, Li X, Hou P, Yu M, Zhang Z, Guo S, Liu C, Zhang Z et al.. Intestinal TGR5-targeted carrier-drug conjugate improves glycemic control in mice and pigs. (2025)  Sci Transl Med, 17 (825): eado5177. [PMID:41259536]

  • MDFIC2 is a PIEZO channel modulator that can alleviate mechanical allodynia associated with neuropathic pain.
    Habib AM, Li S, Zhang C, Ji M, Osorio N, Penalba V, Torres JM, Gossage SJ, Rezai MA, Geard AF et al.. MDFIC2 is a PIEZO channel modulator that can alleviate mechanical allodynia associated with neuropathic pain. (2025)  Proc Natl Acad Sci U S A, 122 (45): e2512426122. [PMID:41201821]

  • Large-scale high-throughput screen for cardiac ryanodine receptor targeted therapeutics.
    Nikolaienko R, Bovo E, Solberg JC, Brinkmann M, Treinen LM, Thompson AR, Berg K, Thomas DD, Thomas JJ, Bers DM et al.. Large-scale high-throughput screen for cardiac ryanodine receptor targeted therapeutics. (2026)  J Biol Chem, 302 (1): 110951. [PMID:41260336]

  • Pathway-selective 5-HT1AR agonist as a rapid antidepressant strategy.
    Wang C, Zhang N, Shao Y, Li T, Zhang M, Gao M, Liang Y, Wang Y, Xue T, Shi Y et al.. Pathway-selective 5-HT1AR agonist as a rapid antidepressant strategy. (2025)  Cell, 188 (25): 7222-7237.e24. [PMID:41232528]

  • Lactylation of mTOR enhances autophagy in skeletal muscle during exercise.
    Li Y, Xue L, Wang F, Wang Y, Sun Y, Niu Z, Liu S, Yan Y, Shen S, Zhang K et al.. Lactylation of mTOR enhances autophagy in skeletal muscle during exercise. (2025)  Cell Chem Biol, 32 (11): 1367-1380.e5. [PMID:41223856]

  • Mechanisms of chemokine recognition and receptor activation of chemokine receptor CCR7.
    Cao Y, Zhang C, Yuan Q, Zhao F, Liu Q, Wu K, Hu W, He J, Li H, Xu HE et al.. Mechanisms of chemokine recognition and receptor activation of chemokine receptor CCR7. (2025)  Cell Rep, 44 (11): 116582. [PMID:41252250]

  • RNA-based drugs: current, imminent and possible therapeutic applications.
    Torrisi SA, Geraci F, Diolosà L, De Luca A, Falzone L, Drago F, Libra M, Leggio GM. RNA-based drugs: current, imminent and possible therapeutic applications. (2026)  Pharmacol Ther, 277: 108958. [PMID:41265758]

  • SLC44A1 deficiency impedes myelin development in the central nervous system.
    Chen Q, Chen X, Li Z, Shao Q, Huang H, Zhou W, Qiu M, Su Z, Liu P, He C. SLC44A1 deficiency impedes myelin development in the central nervous system. (2025)  Cell Rep, 44 (12): 116617. [PMID:41317319]

  • Renal PIEZO2 is an essential regulator of renin.
    Hill RZ, Nelson JW, Gyarmati G, Medrano S, Shirvan S, McCormick JA, Burquez S, Ahmed J, Eng DG, Wysocki J et al.. Renal PIEZO2 is an essential regulator of renin. (2026)  Cell, 189 (1): 161-178.e22. [PMID:41349545]

  • Binding of the brain G protein G⍺o to its potential effector RASA3 is promoted by Ca2.
    Bell HAS, Olson AC, Gentile JE, Lam TT, Koelle MR. Binding of the brain G protein G⍺o to its potential effector RASA3 is promoted by Ca2. (2026)  J Biol Chem, 302 (1): 110999. [PMID:41349768]

  • Inhibition of 15-hydroxy prostaglandin dehydrogenase promotes cartilage regeneration.
    Singla M, Wang YX, Monti E, Bedi Y, Agarwal P, Su S, Ancel S, Hermsmeier M, Devisetti N, Pandey A et al.. Inhibition of 15-hydroxy prostaglandin dehydrogenase promotes cartilage regeneration. (2026)  Science, 391 (6789): 1053-1062. [PMID:41308124]

  • November 2025


  • The functional landscape of coding variation in the familial hypercholesterolemia gene LDLR.
    Tabet DR, Coté AG, Lancaster MC, Weile J, Rayhan A, Fotiadou I, Kishore N, Li R, Kuang D, Knapp JJ et al.. The functional landscape of coding variation in the familial hypercholesterolemia gene LDLR. (2026)  Science, 391 (6787): eady7186. [PMID:41166440]

  • Genomics of drug target prioritization for complex diseases.
    Chen R, Duffy Á, Do R. Genomics of drug target prioritization for complex diseases. (2026)  Nat Rev Genet, 27 (3): 231-245. [PMID:41198831]

  • EMBL's European Bioinformatics Institute (EMBL-EBI) in 2025.
    Thakur M, Bosc N, Brooksbank C, Ernst C, Freeberg MA, Gurwitz KT, Hermjakob H, Hulcoop DG, Martin MJ, McDonagh EM et al.. EMBL's European Bioinformatics Institute (EMBL-EBI) in 2025. (2026)  Nucleic Acids Res, 54 (D1): D10-D19. [PMID:41233952]

  • MGDB: a curated database for molecular glues.
    Li C, Luo H, Pang Y, Liu Y, Luo Y, Liang X, Li H, Li W, Wang L. MGDB: a curated database for molecular glues. (2026)  Nucleic Acids Res, 54 (D1): D1488-D1499. [PMID:41206475]

  • Genome-wide analysis of heart failure yields insights into disease heterogeneity and enables prognostic prediction in the Japanese population.
    Enzan N, Miyazawa K, Koyama S, Kurosawa R, Ieki H, Yoshida H, Takechi F, Fukuyama M, Osako R, Tomizuka K et al.. Genome-wide analysis of heart failure yields insights into disease heterogeneity and enables prognostic prediction in the Japanese population. (2025)  Nat Commun, 16 (1): 9680. [PMID:41184235]